Krystal Biotech, Inc.
KRYS
$256.33
$6.172.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.40M | 79.36M | 38.33M | 35.73M | 45.48M |
| Total Depreciation and Amortization | 762.00K | 512.00K | 508.00K | 669.00K | 455.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.85M | -12.34M | 13.39M | 13.10M | 12.57M |
| Change in Net Operating Assets | 9.50M | -27.88M | 494.00K | -18.54M | -5.66M |
| Cash from Operations | 77.51M | 39.66M | 52.73M | 30.97M | 52.84M |
| Capital Expenditure | -2.14M | -1.70M | -1.90M | -6.20M | -801.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 435.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.30M | -2.58M | -8.62M | -49.00M | -82.98M |
| Cash from Investing | 11.16M | -4.29M | -10.53M | -54.77M | -83.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.69M | 3.71M | 1.80M | 1.46M | 2.43M |
| Repurchase of Common Stock | -23.00K | -5.00K | 0.00 | -13.93M | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.67M | 3.71M | 1.80M | -12.47M | 2.43M |
| Foreign Exchange rate Adjustments | -637.00K | -307.00K | 1.06M | 171.00K | -594.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.70M | 38.78M | 45.06M | -36.10M | -29.10M |